BackgroundMonocyte to high-density lipoprotein cholesterol ratio (MHR) is a novel inflammatory marker of inflammation and oxidative stress and has been used to predict multiple inflammation-related diseases, but data relative to diabetes mellitus are lacking. Hence, our study aimed to explore the impact of MHR on diabetes and its value to improve the risk stratification and prevention of diabetes in a large cohort of general Chinese population.MethodThis study selected 8142 (males: 45.76%) participants who participated in the rural cardiovascular health research in Northeast China between 2012 and 2013. MHR was defined as blood monocyte count ratio to high-density lipoprotein cholesterol concentrationResultsThe prevalence of diabetes is 10.7%. By correcting for potential confounding factors, per SD increase of MHR caused a 11.2% additional risk for diabetes, in addition, the top quartile of MHR increased the risk of diabetes by 33.1% over the bottom quartile.Furthermore, smooth curve fitting showed a linear and strong correlation between MHR and diabetes. Finally, Category-free net reclassification improvement (0.085, 95% CI: 8 0.016-0.155, P = 0.016) and integrated discrimination improvement (0.001, 95% CI: 0.000-0.0024, P = 0.018) also demonstrated significant improvementsConclusionsOur study revealed an independent and robust correlation between MHR and prevalent diabetes mellitus in general population. Furthermore, our results suggest the importance of simultaneous inflammation and lipids control in the prevention of diabetes mellitus, highlighting the value of MHR to optimize the risk stratification and prevention of diabetes mellitus. These findings have implications for the prevention of diabetes and its adverse outcomes.